جست‌وجوی استاد و پژوهشگر

• Metabolic Health
• Skeletal Muscle Physiology
• Alcohol Misuse
• +۵ مورد دیگر

Danielle Levitt, PhD, CSCS*D, serves as an Assistant Professor in the Department of Kinesiology & Sport Management at Texas Tech University and is actively affiliated with the Institute for One Health Innovation. Her research program focuses on metabolic health, investigating how lifestyle factors contribute to dysfunction in health and disease while developing targeted intervention strategies to improve clinical outcomes. Dr. Levitt's core research interests include: Skeletal muscle physiology and bioenergetics Alcohol misuse and its metabolic consequences Glycemic control mechanisms Inter-organ crosstalk in disease states Cardiometabolic risk in vulnerable populations (e.g., people living with HIV, first responders) Exercise physiology interventions Analysis of her recent publications reveals dominant themes in alcohol-pathogen interactions, skeletal muscle regeneration under metabolic stress, and cardiometabolic risk modulation. Her work frequently employs SIV-infected macaque models to study HIV-alcohol comorbidities, explores mTOR signaling pathways in muscle adaptation, and investigates dietary impacts on viral pathogenesis including SARS-CoV-2 susceptibility. Methodologically, she integrates molecular biology, exercise physiology, and epidemiological approaches across diverse populations. No scientific awards were mentioned in the provided documentation. Information regarding Dr. Levitt's graduate student advising, grant funding history, or specific laboratory resources was not included in the source materials. Her research appears to operate through collaborative frameworks within the Institute for One Health Innovation. Dr. Levitt maintains active research operations at Texas Tech University's Institute for One Health Innovation, where she contributes to interdisciplinary initiatives addressing complex health challenges at the human-animal-environment interface through metabolic and physiological research.

Sara K. Olsonمشاهده پروفایل

دانشیار

• Developmental Biology
• Cell Biology
• Molecular Biology
• +۸ مورد دیگر

Sara K. Olson is an Associate Professor of Biology in the Department of Biology at Pomona College, part of The Claremont Colleges. She has been at Pomona since 2012 and is based in Seaver Biology, where she leads a research lab focused on extracellular matrix dynamics during fertilization and early embryonic development in C. elegans . Her research explores the assembly and function of the nematode eggshell, using fluorescence microscopy, molecular genetics (including CRISPR), and biochemical approaches. A major goal is to identify evolutionarily conserved versus divergent mechanisms of eggshell formation, with implications for understanding basic developmental biology and targeting parasitic nematodes. Olson's scientific work has been supported by the National Science Foundation (NSF), the Research Corporation, and the Beckman Foundation. She has led or co-led several major grants, including an NSF CAREER Award and the Beckman Scholars Program. She is also deeply committed to inclusive pedagogy and undergraduate research, frequently involving students in authentic research experiences (CURE-based labs) and co-authoring publications with them. Her recent publications highlight a consistent focus on eggshell permeability, cortical granule exocytosis, proteoglycans, and glycan biology in C. elegans , with increasing integration of CRISPR and educational applications. The research demonstrates a strong interdisciplinary approach combining cell biology, biochemistry, and genetics. Wig Award for Teaching Excellence 7C Faculty Diversity Award for Teaching National Academies Education Fellow NIH IRACDA Postdoctoral Training Award Phi Beta Kappa She advises numerous undergraduate researchers and has mentored multiple students who have co-authored her publications. Her lab operates at the intersection of basic science and science education, promoting accessibility and diversity in STEM. She is also active in national efforts to bring CRISPR technology into undergraduate classrooms through networked teaching initiatives.

Rachelle Crosbieمشاهده پروفایل

استاد

• Duchenne muscular dystrophy
• Protein biochemistry
• Muscle physiology
• +۵ مورد دیگر

Rachelle Crosbie is a Professor and Department Chair at the University of California, Los Angeles (UCLA), specializing in Integrative Biology and Physiology. Her research focuses on Duchenne muscular dystrophy (DMD), sarcospan, and extracellular matrix interactions in muscle health and disease. She earned her B.S. in Biochemistry from Texas A&M University (1989) and her Ph.D. in Biochemistry from UCLA (1994). Postdoctoral work was conducted at the University of Iowa Carver College of Medicine, supported by the Muscular Dystrophy Association. Her lab investigates sarcospan's role in ameliorating dystrophic muscle by activating compensatory mechanisms. Research includes developing small molecule therapies, in vitro platforms for fibrosis studies, and multi-omics approaches to cytoskeletal remodeling. She leads an NIH T32 training grant for muscle research. Scientific awards include the UCLA Chancellor’s Distinguished Teaching Award, Coalition Duchenne Lotus Award, and National Academies Education Scholar recognition. She developed an online DMD course for UC campuses and contributed to education research on student engagement in asynchronous learning.

Kate Beecher Matthewsمشاهده پروفایل

پژوهشگر ارشد

• Breast Cancer
• Neuroscience
• Brain Metastasis
• +۷ مورد دیگر

Dr. Kate Beecher Matthews is an Early Career Postdoctoral Research Fellow at the University of Queensland's UQ Centre for Clinical Research within the Faculty of Health, Medicine and Behavioural Sciences . She works in the Molecular Breast Pathology Lab collaborating with Prof. Sunil Lakhani, A/Prof Amy McCart Reed, A/Prof Peter Simpson, and Dr. Vaibhavi Joshi. Masters (Research) of Biomedical Science, Queensland University of Technology (2018) Doctor of Philosophy, Queensland University of Technology (2022) Dr. Matthews focuses on breast cancer and brain metastasis , with a unique interest in the interaction between the nervous system and breast cancer cells in the brain. Her work integrates neuroscience with oncology , particularly examining serotonin and dopamine signaling in neurocognitive effects of dietary factors and fetal growth restriction . Her recent publications analyze neuroinflammation from high-sugar diets, genomic landscapes of breast cancers, and neurotransmitter regulation in metabolic disorders. She also contributes to neuroscience education through virtual dissection tools. Dr. Matthews is available for research supervision and leads projects on TSPO biomarkers and peer review dynamics in scientific publishing. Her lab work investigates neuroprotective strategies for fetal growth restriction and neural circuits in appetite regulation.

Yuanfang Guanمشاهده پروفایل

استاد

• Bioinformatics
• Computational Biology
• Machine Learning in Medicine
• +۵ مورد دیگر

Professor Yuanfang Guan is affiliated with the University of Michigan in the Department of Computational Medicine and Bioinformatics. Their research focuses on bioinformatics and computational biology applications in medical research. Key research areas include: Computational oncology with emphasis on tumor subclonal reconstruction AI applications in clinical pharmacology and drug response prediction Machine learning for neurogenetic disorders like SCA3 Development of digital health measures for neurological diseases Single-cell sequencing data analysis and quality control Epigenomic data imputation and genomic feature analysis Recent publications highlight collaborative projects on LSD1 inhibitors for sickle cell disease, long COVID prediction models, and optimization of genomic deep learning. Their work involves algorithm development for cancer evolution analysis, disease biomarker identification, and AI-driven biomedical applications.

Saurabh Chatterjeeمشاهده پروفایل

استاد

• Environmental Health
• Microbiome-Immune Interactions
• Neuroinflammation
• +۳ مورد دیگر

Dr. Saurabh Chatterjee is a Professor of Environmental & Occupational Health and Medicine at the University of California, Irvine (UCI) School of Medicine. He is also a research health scientist with the Department of Veterans Affairs at the Long Beach VA Medical Center. Education: Ph.D. in Life Sciences (Inflammation Biology, 2006) from Bhabha Atomic Research Center/University of Mumbai, M.Sc. in Physiology (Immunology, 1997) and B.Sc. (Honors) in Human Physiology (1995) from University of Calcutta, India. Dr. Chatterjee specializes in human physiology and immunology, focusing on host-microbiome interactions with redox biology, neuroimmune pathology, and gut-brain axis dynamics in pro-inflammatory diseases. His work spans Gulf War illness, chronic multisymptom illnesses, liver-brain axis pathologies, and climate change impacts on environmental toxin effects. Recent research trends include climate change stressors like harmful algal blooms, microbiome alterations in neurological diseases, and oxidative stress-epigenomic signaling in inflammatory liver conditions. His lab explores pattern recognition receptors (TLRs, NALP3), Damage-Associated Molecular Patterns, and therapeutic compounds targeting these pathways. Scientific Recognition: Society of Toxicology SIG "Outstanding Early Career Toxicologist" Award (2022) AAAS Invited Panelist on Climate Change and Health (2022) Invited Speaker at Gulf War Illness Research Advisory Council (2021) ASPH Delegation Speaker, Nanjing Medical University (2019) Dr. Chatterjee leads the Chatterjee Lab at UCI, with ongoing projects funded by NIH, DOD, and VA Merit grants. His work integrates environmental toxicology with clinical translation, emphasizing gut-liver-brain axis mechanisms in disease.

• Neurotoxicity Screening
• Developmental Neurotoxicity
• Environmental Toxicology
• +۳ مورد دیگر

Gina van Kleef is a Researcher and Teacher at the Faculty of Veterinary Medicine , Utrecht University , affiliated with the Institute for Risk Assessment Sciences (IRAS) and Department of Population Health Sciences . Her work focuses on neurotoxicity screening , developmental neurotoxicity , and environmental health using in vitro and hiPSC-derived neuronal models . Specializes in occupational health & safety and environmental toxicology Employing microelectrode array (MEA) recordings for neurotoxicity assessment Research trends from 2025-2020 reveal her focus on: Chemical neurotoxicity (insecticides, PFAS, flame retardants) Viral neurotoxicity (Enterovirus D-68, snake venom) Neurotransmitter receptor interactions (GABAA, nicotinic acetylcholine receptors) Novel assay development for high-throughput toxicity screening Contact: g.vankleef@uu.nl Location: Jeannette Donker-Voetgebouw, Yalelaan 104-106, Utrecht

Raag Airanمشاهده پروفایل

استادیار

• Neuroimaging
• Neurointervention
• Ultrasound Techniques
• +۳ مورد دیگر

Raag Airan is an Assistant Professor of Radiology (Neuroimaging and Neurointervention) and by courtesy, Materials Science and Engineering at Stanford University. His work bridges Noninvasive nervous system manipulation Ultrasound and nanoparticle engineering Theranostic applications Behavioral neuroscience His research focuses on Ultrasound-mediated drug delivery systems Neuroimaging of functional connectivity Neuromodulation for chronic pain and psychiatric disorders Glymphatic system modulation Recent publications highlight advancements in Acoustically activatable liposomes Sex-based pharmacological responses Algorithmic psychiatry frameworks Stem cell therapy imaging Deep learning-enhanced ultrasound

• Epilepsy
• Drug-Resistant Epilepsy
• Tumor-Related Epilepsy
• +۷ مورد دیگر

Robert A. Rifkin, MD, PhD is an Assistant Professor of Neurology in the Section of Epilepsy at Yale School of Medicine. His clinical expertise includes adult epilepsy , with a focus on drug-resistant and tumor-related epilepsy . Education & Training MD and PhD in Biomedical Science, Icahn School of Medicine at Mount Sinai Intern and Resident, Columbia University Irving Medical Center (2020, 2023) Clinical Neurophysiology and Epilepsy Fellowships, Columbia University Irving Medical Center (2024, 2025) Research Interests center on the role of inwardly-rectifying potassium channels in addiction and epilepsy , supported by NIDA F30 and NINDS R25 grants . His work explores molecular mechanisms like GIRK currents in VTA dopamine neurons and GIRK3 subunit function in methamphetamine effects. Publications highlight collaborations in neuropharmacology and medical education , with recent studies on small-molecule agonists for seizure reduction and health disparities in student-run clinics. He is board-certified in Neurology by the American Board of Psychiatry and Neurology (2023). Clinical Care is provided at Yale Physicians Building, New Haven, CT, and Yale Medicine Multispecialty locations. Contact: Yale School of Medicine , Academic Office (203.785.3865), Appointment (203.785.6368).

Shijie Caoمشاهده پروفایل

استادیار

• Biotechnology
• Chronic Disease
• Drug Formulation
• +۷ مورد دیگر

Dr. Shijie Cao serves as an Assistant Professor in the Department of Pharmaceutics at the University of Washington School of Pharmacy, where he leads the Cao Lab focused on innovative drug delivery approaches for immunological disorders. His research bridges pharmaceutical sciences with immunology to develop novel therapeutic strategies targeting the microbiome and immune system. Dr. Cao earned his Bachelor of Science in Pharmacy from Fudan University in Shanghai, China in 2013, followed by a PhD in Bioengineering from the University of Washington in 2018. He completed postdoctoral training in Molecular Engineering at the University of Chicago from 2019-2023 before joining the UW faculty in June 2023. His research program centers on mucosal immunoengineering and microbiome pharmaceutics , with the goal of developing translatable tools to prevent and treat immunological disorders including allergies, inflammation, autoimmune diseases, and infectious diseases. The lab specifically focuses on developing therapeutics that modulate the immune system by targeting the microbiome and its associated metabolites. By leveraging advanced drug delivery tools and microbiome modulation strategies, Dr. Cao's team aims to unravel the complex interplay between the microbiome and various organ systems to improve human health. Analysis of Dr. Cao's recent publications reveals a strong trajectory in developing microbiome-targeted therapies, particularly using butyrate and other microbial metabolites for autoimmune conditions and food allergies. His work demonstrates increasing sophistication in delivery systems, with recent publications focusing on glycosylation-modified antigens for tolerance induction, serine-conjugated butyrate prodrugs with high oral bioavailability, and injectable butyrate-prodrug micelles for long-acting immune modulation. The research spans applications from autoimmune arthritis and neuroinflammation to peanut allergy treatment and chronic wound healing. Dr. Cao actively collaborates with prominent researchers including Jeffrey A. Hubbell and maintains strong connections with his previous mentors at the University of Chicago. His work frequently appears in high-impact journals including Nature Biomedical Engineering, Cell Reports Medicine, and Biomaterials, reflecting the significance and innovation of his contributions to pharmaceutical sciences. The Cao Lab is currently accepting graduate students and maintains active research programs in two primary areas: developing tolerance-inducing vaccines for food allergies and autoimmune conditions, and creating microbiome-targeted delivery systems for inflammatory and autoimmune diseases. The lab employs interdisciplinary approaches combining nanotechnology, immunology, and microbiome science to address unmet medical needs in immune-mediated disorders.

Hana Kammounمشاهده پروفایل

پژوهشگر ارشد

• Immunology
• Microbiology
• Infectious Diseases
• +۲ مورد دیگر

Hana Kammoun is a postdoctoral fellow at the Institut Pasteur in the Biology of Infection Unit since 2018. Her research focuses on Vaccinology Immunology Infectious disease mechanisms Mucosal immunity Her work emphasizes live attenuated vaccine strategies using Bordetella pertussis (BPZE1) to combat respiratory pathogens like influenza and pertussis. She obtained a PhD in Biotechnology (2009-2012) from Lille2 University Master 2 in Genetics and Microbiology (2008-2009) from Lille2 University Engineering degree in Industrial Biology (2003-2008) from INSAT Her postdoctoral experience includes positions at Karolinska Institute's Center for Infectious Medicine (2015-2017) INSERM U1019-CNRS UMR8204's Center for Infection and Immunity of Lille (2013) Lille2 University's CIIL unit during her PhD (2008-2012) Her publications reveal a focus on Live attenuated vaccine development Immune response modulation Cross-protective immunity against Bordetella species Th1/Th17 vs. Th2 immune polarization Long-term mucosal immunization strategies Role of innate lymphoid cells in intestinal homeostasis She has mentored Ranabir Chakraborty (PhD candidate) Paul Courrieu (Master's student) in academic teams at Institut Pasteur and affiliated institutions.

• Structural Biology
• Protein-Nucleic Acid Interactions
• Crystallography
• +۳ مورد دیگر

Charles Bond is a Professor at the School of Molecular Sciences within the Faculty of Science at the University of Western Australia. With a PhD in Chemistry from the University of Manchester and additional training from the Australian Institute of Company Directors, he has established himself as a prominent researcher in structural biology and molecular interactions. Education: PhD in Chemistry, University of Manchester (1992-1996) Graduate, Australian Institute of Company Directors (2022) Bond's research focuses on understanding how the spatial arrangement of biological molecules in complexes dictates their function, with particular interest in protein:nucleic acid interactions and their roles in gene regulatory complexes in eukaryotes. His work combines expertise in crystallography, bioinformatics, biochemistry, and molecular biology, often through collaborations with experts in cell biology and other biophysical techniques. His research spans structural biology, molecular recognition, RNA-binding proteins, and the development of synthetic biology tools. Analysis of his recent publications reveals a strong emphasis on protein-nucleic acid interactions, structural dynamics of biomolecular complexes, and the application of structural biology to solve biological problems. His work increasingly incorporates computational approaches, including contributions to discussions about AlphaFold's impact on structural biology. He has made significant contributions to understanding pentatricopeptide repeat proteins, paraspeckle formation, and bacterial conjugation mechanisms. As an active member of the scientific community, Bond serves as a co-editor for Acta Crystallographica Section D and has reviewed for multiple high-impact journals including Nature Communications, Biochemistry, and The Plant Cell. His research has been supported by funding from the Marsden Fund for projects investigating molecular circuits and gene expression. Bond maintains an active laboratory focused on structural biology approaches to understand molecular interactions, with particular emphasis on protein-RNA complexes and their roles in cellular processes. His collaborative approach has led to productive partnerships across multiple disciplines, bridging structural biology with cell biology, biochemistry, and agricultural science.

Thomas Leonardمشاهده پروفایل

استاد

• Lipid signaling
• Protein kinases
• Signal transduction
• +۵ مورد دیگر

Thomas Leonard is a tenured Professor at the Max Perutz Labs (University of Vienna), where he leads a research group focused on lipid-mediated signal transduction and structural mechanisms of kinase regulation . His lab combines structural biology , biochemistry , and cell biology to dissect how cells integrate spatial and temporal signals. PhD in Structural Biology (MRC Laboratory of Molecular Biology, Cambridge) Postdoctoral work at NIH, Bethesda His research explores how lipid second messengers like PIP3 and PI3P control kinases such as Akt, PDK1, and Sgk3, with implications for cancer , neurodevelopmental disorders , and metabolic diseases . Recent work redefined PHLPP1/2 as pseudophosphatases and revealed novel activation mechanisms in Protein Kinase D (PKD) and DMPK kinases. The lab's publication trends highlight structural phylogenomics , membrane scaffolding , and allosteric regulation . Collaborations with institutions like LMU Munich and FWF-funded projects underscore their interdisciplinary approach. Lab Manager: Ronja Reinhardt PhD Students: Sumire Antonioli, Magdalena Otto, Lucas Piech, Eva Krotenheerdt, Felix Wolkenstein Master Students: Gabriela Ariza, Emese Galgóczi, Stefan Lenz The lab actively recruits at Master, PhD, and Postdoc levels for molecular signaling research.

Ronald Dijkmanمشاهده پروفایل

دانشیار

• Respiratory virology
• Coronaviruses
• Influenza viruses
• +۵ مورد دیگر

PD Dr. Ronald Dijkman is Group Leader of the Experimental Virology Research Group within the Institute for Infectious Diseases (IFIK) at the University of Bern Medical Faculty. His laboratory is located at the Multidisciplinary Center for Infectious Diseases (MCID) , underscoring his central role in Swiss infectious-disease research infrastructure. Education & Training: While the supplied pages do not list explicit degrees, the title PD Dr. indicates that he has completed a PhD, post-doctoral training, and the Germanic Habilitation, qualifying him as an Associate Professor-level faculty member. Research Focus: Dr. Dijkman’s team investigates host–pathogen interactions in the respiratory epithelium , concentrating on three pillars: Innate immunity triggered by influenza and coronaviruses in human and animal airway epithelial cells. Viral genetic determinants that modulate immune evasion and cross-species transmission. Host determinants that either restrict or facilitate infection across species barriers. To dissect these questions, the group has pioneered genetically-tractable, well-differentiated primary airway epithelial cell (AEC) cultures derived from humans, pigs, cattle and bats, creating a unique comparative platform for zoonotic-risk assessment. Funding & Collaborative Networks: His research is currently supported by: Swiss National Science Foundation (SNF) – project on Molecular characterization of Influenza D virus–host interactions . EU Marie Skłodowska-Curie ITN “HONOURs” – a multi-partner training network on host-switching pathogens and zoonoses. Federal BLV grant – implementation of nanopore sequencing for rapid identification of OIE-notifiable animal viruses. These grants enable a team of one post-doc and four PhD students, together with technical staff. Scientific Output & Impact: Since 2010, Dr. Dijkman has authored >60 peer-reviewed articles. His work on SARS-CoV-2 reverse genetics (Nature, 2020), MERS-CoV receptor usage (Nature, 2014) and single-cell influenza pathogenesis (bioRxiv, 2020–22) has been highly cited, reflecting broad scientific impact. Laboratory & Team: The Experimental Virology group occupies BSL-2 and BSL-3 laboratories equipped with state-of-the-art live-cell imaging, lentiviral genetic engineering, and nanopore sequencing pipelines. The group presently comprises: Larise Oberholster – Early Post-doc Alina Baltensperger – PhD student Jean-Claude Makangara – PhD student Mike Javan Mwanga – PhD student Karen Stevers – PhD student Cinzia Moscardelli – laboratory technician

Zalfa Abdel-Malekمشاهده پروفایل

استاد

• Melanocyte Biology
• UV Radiation Response
• Melanoma Prevention
• +۴ مورد دیگر

Zalfa Abdel-Malek is a distinguished Professor in the Department of Environmental Health at the University of Cincinnati College of Medicine, where she has maintained an active research program for over two decades. Her work bridges dermatology, molecular biology, and environmental health, focusing on the mechanisms of skin pigmentation and melanoma development. Her educational background includes a Bachelor's degree in Biology from the American University of Beirut (1974), followed by Master's (1980) and Doctoral degrees (1984) in General Biology from the University of Arizona. She completed postdoctoral training in Dermatology at the University of Cincinnati in 1987, establishing her long-standing relationship with the institution. Dr. Abdel-Malek's research centers on the melanocortin 1 receptor (MC1R) and its role in regulating cutaneous pigmentation and the response to UV radiation. She pioneered work demonstrating that human melanocytes express functional MC1R and that activation of this receptor is critical for the tanning response to UV. Her laboratory discovered that activated MC1R enhances the repair of UV-induced DNA damage, maintaining genomic stability of melanocytes and preventing malignant transformation to melanoma. This work has led to the development of small peptide analogs of α-MSH that could potentially serve as topical agents for melanoma prevention. Analysis of her recent publications reveals a consistent focus on MC1R signaling pathways, DNA repair mechanisms in melanocytes, and the development of melanocortin-based therapeutics for melanoma prevention. Her work increasingly explores the tumor microenvironment, genetic interactions between MC1R variants and other melanoma susceptibility genes, and translational applications of basic research findings. Vitiligo Research Award (1990) from the PanAmerican Society for Pigment Cell Research Aaron B. Lerner Award (2006) from the PanAmerican Society for Pigment Cell Research Myron Gordon Award (2011) from the International Federation for Pigment Cell Societies Dr. Abdel-Malek has secured continuous funding as Principal Investigator on numerous NIH grants, including multiple R01 awards from NIEHS and NCI, as well as funding from the Department of Defense and industry partners. Her current research program includes testing small peptide analogs of α-MSH for melanoma prevention, investigating the impact of MC1R variants on DNA damage response, and exploring novel paradigms in melanoma prevention. She maintains active collaborations with researchers across multiple institutions, particularly with Ana Luisa Kadekaro and other colleagues at the University of Cincinnati.